Ivy Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Ivy Capital is a premier venture capital and growth equity firm that finances early- or growth-stage companies.
Investor Profile
Ivy Capital has made 11 investments, with 2 in the past 12 months and 9% as lead.
Stage Focus
- Series C (36%)
- Series Unknown (27%)
- Series A (18%)
- Series E (9%)
- Series B (9%)
Country Focus
- China (73%)
- United States (27%)
Industry Focus
- Medical
- Information Technology
- Biotechnology
- Software
- Health Care
- Biopharma
- Clinical Trials
- Cloud Computing
- Pharmaceutical
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
